Almira Blazek-Welsh

Almira Blazek-Welsh has a diverse work experience in the pharmaceutical industry. Almira currently serves as the Manager of CMC Operations at Zucara Therapeutics Inc., starting in May 2021. Prior to this, they held the role of Senior Specialist in CMC at Methylation Sciences Inc from December 2009 to June 2018. Almira also worked as a Senior Specialist in Pharmaceutics at Cardiome Pharma Corp from November 2007 to September 2009. Almira's previous experience includes working as a Senior Scientist II at AnorMED from May 2003 to September 2007. Almira began their career as a Postdoctoral Scientist at the School of Pharmacy, University of Connecticut from February 1999 to July 2002, and prior to that, they worked as a Doctoral/Postdoctoral Student at the Department of Chemistry, University of British Columbia from September 1992 to February 1999.

Almira Blazek-Welsh holds a Ph.D. in Physical Chemistry, which they obtained from The University of British Columbia from 1992 to 1998. Prior to that, they completed their undergraduate studies at the University of Victoria from 1987 to 1992, earning a B.Sc. in Chemistry. In addition to their academic degrees, Almira holds a Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professionals Society (RAPS). No specific information is available regarding when they obtained this certification.